about
The telomere syndromesRoles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapiesTelomere biology: Rationale for diagnostics and therapeutics in cancerProgress in structural studies of telomeraseTelomerase as a Cancer Target. Development of New MoleculesAlternative Splicing of hTERT Pre-mRNA: A Potential Strategy for the Regulation of Telomerase Activity.Telomerase and hTERT: can they serve as markers for gastric cancer diagnosis?Telomere Biology-Insights into an Intriguing Phenomenon.Exploring the Dynamics of Propeller Loops in Human Telomeric DNA Quadruplexes Using Atomistic Simulations.Crosstalk between telomere maintenance and radiation effects: A key player in the process of radiation-induced carcinogenesis.Diverse modes of genomic alteration in hepatocellular carcinomaA minimal connected network of transcription factors regulated in human tumors and its application to the quest for universal cancer biomarkersMolecular and cellular functions of the FANCJ DNA helicase defective in cancer and in Fanconi anemiaA small molecule inhibitor of Pot1 binding to telomeric DNA.Telomere maintenance mechanisms in cancer: clinical implicationsRole of telomeres and telomerase in cancerOptimization of a gene electrotransfer procedure for efficient intradermal immunization with an hTERT-based DNA vaccine in miceTelomerase inhibition decreases alpha-fetoprotein expression and secretion by hepatocellular carcinoma cell lines: in vitro and in vivo study.Maintaining the end: roles of telomere proteins in end-protection, telomere replication and length regulationMre11 and Blm-Dependent Formation of ALT-Like Telomeres in Ku-Deficient Ustilago maydis.Conditional Knockout of Telomerase Reverse Transcriptase in Mesenchymal Cells Impairs Mouse Pulmonary Fibrosis.Therapeutic inhibition of TRF1 impairs the growth of p53-deficient K-RasG12V-induced lung cancer by induction of telomeric DNA damageDNA helicases involved in DNA repair and their roles in cancerHit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement.The correlation between telomerase activity and Bax/Bcl-2 ratio in valproic acid-treated MCF-7 breast cancer cell lineMulti-Modal Imaging in a Mouse Model of Orthotopic Lung CancerTelomerase as a useful target in cancer fighting-the breast cancer case.Role of Telomeres and Telomerase in Aging and Cancer.Acacetin and chrysin, two polyphenolic compounds, alleviate telomeric position effect in human cells.Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.Genistein suppresses the proliferation of telomerase-negative cells.Fundamental mechanisms of telomerase action in yeasts and mammals: understanding telomeres and telomerase in cancer cells.Telomerase-independent paths to immortality in predictable cancer subtypes.Fluorescent probes for G-quadruplex structures.Portrait of replication stress viewed from telomeres.Breast cancer immunotherapy: monoclonal antibodies and peptide-based vaccines.Telomerase promoter mutations in cancer: an emerging molecular biomarker?Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer CellsA combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines.The effect of benzyl isothiocyanate and its computer-aided design derivants targeting alkylglycerone phosphate synthase on the inhibition of human glioma U87MG cell line.
P2860
Q24632444-0DB145EA-F1A0-4425-BC67-320DA7875788Q26744271-B496C0AA-AFDF-4F22-94BB-0913286E39F5Q26796323-3E7717BB-440D-4992-8AAD-33F28093EECEQ27024292-FBE986F0-4EC1-4D6A-8653-FF1FE9C32E6CQ28079188-A54E9075-B960-4890-8F87-BDE8BF2EEE43Q30235386-F33C64CC-57F7-494A-94D3-53864E35D7B7Q33718336-5FC64C51-4ACB-4BA2-9813-0515E6907411Q33855946-5E5802E7-073A-43DB-A78E-B225B9AD262DQ33912756-A950CB7F-B1A6-4EED-89BB-74A9D64DD136Q33990112-9330548D-813F-42F0-BADE-CFA60D322176Q34306010-04A98C3F-5562-4BAC-88BD-C99F54AD5BFFQ34326409-4F23810B-13EC-4BE2-8EAB-E94981CB01FEQ34377302-8532A754-7D54-4E2D-96FA-34B3460146AFQ34414940-707BDAB7-E601-46E2-915A-61B7450F31F4Q34426966-C14DDADE-A9AA-4F28-AB55-6438E7E70811Q34633162-6B165541-A689-42E0-AA34-920BAC512A3DQ35184204-EDEAEAE6-C7B2-4200-A76A-9C556CA842CCQ35590195-F55D8A61-2B92-464D-A176-DD80BA003711Q35667156-3E079813-BC94-40C9-8911-71D4DEF80A71Q35817236-4047BF57-D42C-4431-A7AE-DA2267C78CA8Q35837601-FA14E0C1-3601-4F36-929E-8E4D956AAB28Q35904248-B308F331-EB20-4270-9006-A0BAC47EC76FQ35961508-B90F6347-5A90-4AF7-BC2D-B319089E0656Q35967905-72B27DE2-2EEE-42A4-B9A2-505DB6DB78A0Q36017178-69801018-EC48-4C23-BE96-2BE5B7683D0CQ36119987-5EEE89F4-81AF-4548-84BD-5ABEE4E640D9Q36868580-22C793B7-6B86-4773-8DF5-59DC98580D13Q36971261-79B23633-8ADA-49E0-B1B2-C27F7A98CB8EQ37138708-50818E7E-E1BA-4B68-AC3A-5730D3F90AB5Q37362475-34319776-B757-4EEF-A755-7D448C709288Q37675160-82467100-0FE0-43F6-9847-50F44D88C459Q37733930-F6473F0F-2672-451A-A9C0-2DB0E2DAEA56Q37982375-19176ED0-230C-4957-9000-5EC1EEAD0B1BQ38084623-CF35DF12-3764-4692-B0A3-3AFA5BEA9CBCQ38096021-45549626-4251-41F3-BB2D-DC3FD6BA1894Q38215394-06FF7177-010F-4051-A0E5-8F0C8F1B0B7DQ38232447-B446C821-135C-4212-B074-EE7EB4395030Q38700449-29A425B6-15AA-4584-95CC-39591503A585Q38881802-7B84EB03-E2EA-4439-B0DB-B9217CE1BFC9Q38925261-6CB0CAF0-3012-422E-8CA1-7BC68EC3A916
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Is telomerase a viable target in cancer?
@en
Is telomerase a viable target in cancer?
@nl
type
label
Is telomerase a viable target in cancer?
@en
Is telomerase a viable target in cancer?
@nl
prefLabel
Is telomerase a viable target in cancer?
@en
Is telomerase a viable target in cancer?
@nl
P2093
P2860
P1433
P1476
Is telomerase a viable target in cancer?
@en
P2093
P2860
P356
10.1016/J.MRFMMM.2011.07.006
P407
P577
2011-07-23T00:00:00Z